VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 8 analysts with an average price target of $41.36. This is a potential upside of $19.2 (86.64%) from yesterday's end of day stock price of $22.16.

Viridian Therapeutics's activity chart (see below) currently has 119 price targets and 105 ratings on display. The stock rating distribution of VRDN is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.05% with an average time for these price targets to be met of 108.88 days.

Highest price target for VRDN is $46, Lowest price target is $26, average price target is $35.63.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 21-Oct-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 20 are a BUY (90.91%), 2 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$36

$13.84 (62.45%)

$32

5 days ago
(21-Oct-2025)

0/8 (0%)

$11.98 (49.88%)

Hold

$26

$3.84 (17.33%)

$27

2 months 19 days ago
(07-Aug-2025)

0/3 (0%)

$9.47 (57.29%)

Buy

$30

$7.84 (35.38%)

$27

2 months 19 days ago
(07-Aug-2025)

1/5 (20%)

$13.47 (81.49%)

112

Buy

$34

$11.84 (53.43%)

$36

2 months 20 days ago
(06-Aug-2025)

0/17 (0%)

$16.8 (97.67%)

Buy

$38

$15.84 (71.48%)

$38

5 months 19 days ago
(07-May-2025)

2/8 (25%)

$25.71 (209.19%)

369

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 108.88 days on average for the stock forecasts to be realized with a an average price target met ratio 13.05

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 6 price targets and 4 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Julian Harrison with highest potential upside - $38.84

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Kalpit Patel with lowest potential downside - -$0.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?